SMOKABLE CANNABIS-BASED PRODUCT WITH REDUCED PSYCHOACTIVE EFFECTS
A method of preparing a smokable cannabis -based product with reduced psychoactive effects and method for producing the same, comprising the steps of: (a) separating portions with known low tetrahydrocannabinol content from harvested plant material of the cannabis ; (b) separating plant matter which has previously been used in a cannabis oil extraction process; (c) combining specific amounts of the separated materials to produce a cannabis plant material mixture possessing a specific active cannabis compound profile using a mixing device; and (d) loading the mixture of cannabis plant material into the cylindrical smokable tube using a loading device.
1 . A method of preparing a smokable cannabis -based product with reduced psychoactive effects and method for producing the same, comprising the steps of:
(a) separating low-content plant matter from harvested plant material of a cannabis plant, the low-content plant matter having known low tetrahydrocannabinol content and at least a portion of the plant material comprising cannabis plant fan leaves of the cannabis plant;
(b) selecting used plant matter which has previously been used in a cannabis oil extraction process;
(c) combining a portion of each of the low-content plant matter and the used plant matter to produce a cannabis plant material mixture using a mixing device, the cannabis plant material mixture possessing a specific active cannabis compound profile, wherein the cannabis plant material mixture comprises one or more cannabis strains each expressing known concentrations of a plurality of active cannabis compounds, the known concentrations being determined using an extract from each cannabis strain and expressed as a ratio of weight-of-compound per weight-of-extract; and
(d) loading the cannabis plant material mixture into a cylindrical smokable tube using a loading device.
2 . The method of claim 1 , wherein the cannabis compound profile formulation comprises at least 10% by weight of purified Δ-9-tetrahydrocannabinol.
3 . The method of claim 1 , wherein the cannabis compound profile formulation at least 45% by weight of purified cannabidiol.
4 . The method of claim 1 , wherein the cannabis plant material mixture further comprises hemp plant matter.
5 . The method of claim 1 , wherein the cannabis compound profile formulation comprises at least 5% by weight of purified β-myrcene.
6 . The method of claim 1 , further comprising cannabis compounds chosen from a set comprising myrcene, α pinene, ocimene, terpineol, beta-caryophyllene, linalool, limonene, terpinolene, valencene, geraniol, phellandrene, carene, terpinene, fenchol, borneol, bisabolol, phytol, camphene, sabinene, camphor, isoborneol, menthol, cedrene, nerolidol, guaiol, isopulegol, geranyl, cymene, and eucalyptol.
7 . A smokable therapeutic cannabis -based product produced according to the method of claim 1 .
8 . A smokable therapeutic cannabis -based product produced according to the method of claim 2 .
9 . A smokable therapeutic cannabis -based product produced according to the method of claim 3 .
10 . A smokable therapeutic cannabis -based product produced according to the method of claim 4 .
11 . A smokable therapeutic cannabis -based product produced according to the method of claim 5 .
12 . A smokable therapeutic cannabis -based product produced according to the method of claim 6 .